Cambridge Bay joins Nunavut’s COVID-19 list
94 cases of respiratory disease confirmed in nine communities since Dec. 21
COVID-19 has been detected in Cambridge Bay, bringing to nine the number of Nunavut communities with active cases of the disease, the territorial government reported Thursday in a news release.
There are 94 cases across the territory, an increase of 20 compared to Wednesday’s count.
The number of cases in each community is as follows:
- Iqaluit — 31
- Rankin Inlet — 28
- Pangnirtung — 13
- Sanirajak — 10
- Arviat — 6
- Cambridge Bay — 2
- Qikiqtarjuaq — 2
- Igloolik — 1
- Baker Lake — 1
“The seriousness of the Omicron variant and how it is overwhelming our health-care system cannot be overstated,” chief public health officer Dr. Michael Patterson said, referring generally to the pressure Omicron has put on the system across Canada.
Omicron has still not yet been confirmed in Nunavut, Health Department spokesperson Chris Puglia said.
Patterson repeated his calls for people to stay home, not to gather with other people, wear a mask and get vaccinated. Shopping should be done by one person from each household to limit the number of people going into stores.
The Government of Nunavut also reminded Nunavummiut of travel restrictions in place for Iqaluit, Rankin Inlet, Pangnirtung, Sanirajak, Igloolik and Arviat. Travel to and from those communities is restricted to essential purposes only, the GN said.
People who develop COVID-19 symptoms should call the GN’s hotline at 1-888-975-8601. The GN asked people to be patient because there are longer-than-normal wait times to get through. The government reminded people not to go to a health centre in person.
COVID-19 symptoms include runny nose, cough, sore throat, fever or difficulty breathing.
Vaccines are available to everyone over the age of five years. Booster shots are available to people who are 18 years old and older whose second dose was at least four and a half months ago. For teens between 12 and 17, boosters are available six months after their second dose.